EGI
AMPH icon

EAM Global Investors’s Amphastar Pharmaceuticals AMPH Stock Holding History

EAM Global Investors’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-48,505
Closed -$1.69M – 175
2022
Q2 		$1.69M Sell
48,505
-43,197
-47% -$1.54M 0.41% 114
2022
Q1 		$3.29M Buy
+91,702
New +$2.6M 0.61% 41
2019
Q1 		– Sell
-62,426
Closed -$1.24M – 128
2018
Q4 		$1.24M Buy
+62,426
New +$1.23M 0.68% 74

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

EAM Global Investors's AMPH Position: Q3 2022 in Review

EAM Global Investors sold out of Amphastar Pharmaceuticals (AMPH) in Q3 2022, closing a stake of 48,505 shares — an estimated $1.69M sold.

EAM Global Investors first reported a position in AMPH in Q4 2018 and held it in 3 quarters. The position peaked at $3.29M in Q1 2022. 205 funds tracked by Wall St. Rank hold AMPH as of Q3 2022.

  • EAM Global Investors reported no remaining Amphastar Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • EAM Global Investors sold 48,505 Amphastar Pharmaceuticals shares in Q3 2022, an estimated $1.69M.
  • EAM Global Investors first reported a position in Amphastar Pharmaceuticals in Q4 2018 and held it in 3 quarters.
  • EAM Global Investors's Amphastar Pharmaceuticals position peaked at $3.29M in Q1 2022.
  • 205 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2022.

Based on EAM Global Investors's 13F filing for Q3 2022, filed 14 Nov 2022.